SCHEMBL20053845

SCHEMBL20053845

CCc1cnc(Nc2ccc3c(c2)CCN2CCNCC32)nc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 2/20 0.54
BRD4 O60885 2/20 0.54
JAK1 P23458 1/20 0.53
BRD2 P25440 1/20 0.53
JAK3 P52333 1/20 0.53
BRD3 Q15059 1/20 0.53
BRDT Q58F21 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17552273 1.00 JAK2 (0.54) JAK2BRD4JAK1BRD2JAK3
SCHEMBL18863130 0.85 JAK2 (0.55) JAK2BRD4
SCHEMBL17552263 0.85 TAAR1 (0.55)
SCHEMBL20053857 0.85 TAAR1 (0.55)
SCHEMBL20053846 0.84
SCHEMBL17552261 0.84
SCHEMBL18863140 0.82
SCHEMBL17552247 0.82
SCHEMBL17552308 0.80 TAAR1 (0.59)
SCHEMBL20053856 0.80 TAAR1 (0.59)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3186250-B1 SUBSTITUTED PYRAZINO[2,1-A]ISOQUINOLINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS HOFFMANN LA ROCHE (CH) 2018-04-18 EP disclosed